With the product from Australian company Ellume, users can swab themselves at home and check their status in about 20 minutes
MONDAY, Feb. 1, 2021 (HealthDay News) — The U.S. government has awarded a $231 million contract for production of a recently approved over-the-counter COVID-19 home test kit.
With the product from Australian company Ellume, users can swab themselves at home and check their status in about 20 minutes. It is one of only three consumer self-use tests and the only one available without a doctor’s prescription, the Associated Press reported.
Ellume said it would use the contract to build a U.S. manufacturing plant and deliver 8.5 million tests for federal use, but the company did not give a delivery timeframe.
Health experts have long emphasized the need for fast, widespread home testing, but the vast majority of tests still require a nasal swab to be taken by a health worker and sent to a lab for processing, the AP reported.
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens 
Genetic Screening Can ID Hemoglobinopathy Prevalence 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
Research Challenges Fusion for Lumbar Degenerative Spondylolisthesis 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline 
Disparities Identified in Home Health Care After Hip, Knee Replacement 
